Korea University Guro Hospital
151
17
24
71
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.6%
7 terminated/withdrawn out of 151 trials
91.0%
+4.5% vs industry average
36%
55 trials in Phase 3/4
6%
4 of 71 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (151)
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
Role: collaborator
Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
Role: collaborator
Anesthesia and Non-small Cell Lung Cancer Recurrence
Role: collaborator
Long-term Prospective Study of Korean CADASIL Patients
Role: collaborator
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
Role: collaborator
Oncometabolic Surgery
Role: lead
Drug-Coated Balloon in Patients With High Bleeding Risk
Role: collaborator
Prospective CT Assessment After DCB
Role: collaborator
OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
Role: lead
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Role: collaborator
Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients
Role: lead
Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
Role: lead
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
Role: lead
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
Role: collaborator
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
Role: lead
Alternative Surveillance Program for Patients With High Risk Group of HCC
Role: collaborator
PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF
Role: collaborator
Efficacy and Safety of CBT on Tinnitus
Role: lead
Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers
Role: lead
Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Role: lead